Pharma stock under Rs 50 to be in focus as company approves allotment of 90,00,000 equity shares: Details

Shares of speciality chemicals company Sudarshan Pharma Industries Limited will be in focus during today's trading session, i.e. on June 15, 2026, as the company has announced a fresh expansion of its equity base. According to the information shared with exchanges, the company's warrants committee has approved the allotment of 90,00,000 equity shares to prominent individuals within the company's promoter category. These equity shares with a face value of Re 1 each have been cleared at an issue price of Rs 16.983 per share. This includes a premium of 15.983 per share. This transaction is the direct result of the conversion of 9,00,000 original warrants. These warrants were distributed on a preferential basis at an original issue price of Rs 169.83 each.